Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

P&U discloses inhibitors of enzyme involved in neurodegenerative diseases

June 10, 1997

Astra describes new topical anesthetics

June 10, 1997

Lipid peroxidation inhibitors from Gyogyszerkutato Intezet

June 10, 1997

Transdermal buspirone patch shows encouraging results in ADHD

June 9, 1997

Millennium BioTherapeutics discovers novel chemokine implicated in brain inflammation

June 9, 1997

DHEA enters phase II/III trials

June 9, 1997

New pharmacological data reported for Novo Nordisk/Lilly muscarinic agent

June 9, 1997

Cerebroprotective activity of novel free radical scavenger established in animal model

June 9, 1997

Preclinical neuroprotective activity of P&U antioxidants

June 9, 1997

Tachykinin antagonists prepared by Merck & Co.

June 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...